Quarter Financials

Galectin Therapeutics Inc. (GALT)

$1.8895

-0.03 (-1.59%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands , Years are calendar years not fiscal years

Retained Earning Schedule

Year 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3
Net Income -9-12-30-9-10-10-7-9
Dividend Paid --0-0--0-0-0-
Retained Earnings -330-321-310-299-290-281-271-263

PPE Schedule

Year 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3
Capital Expenditure --------
Net PPE -1110000

Intangible and Goodwill Schedule

Year 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3
New Purchases --------
Intangible and Goodwill --------